Morphological and p40 immunohistochemical analysis of squamous differentiation in endoscopic ultrasound guided fine needle biopsies of pancreatic ductal adenocarcinoma.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
28 10 2021
Historique:
received: 10 11 2020
accepted: 14 10 2021
entrez: 29 10 2021
pubmed: 30 10 2021
medline: 28 1 2022
Statut: epublish

Résumé

The basal-like molecular subtype of pancreatic ductal adenocarcinoma (PDAC) is associated with poor prognosis and upregulation in TP63ΔN (p40) network. Adenosquamous histology can be observed. This study assessed immunohistochemical p40 expression in fine needle biopsy (FNB) samples with PDAC and association with cytomorphological features of squamous differentiation and clinical data. 106 EUS FNBs with PDAC were assessed for eight cytomorphological features of squamous differentiation. P40 H-score (intensity 0-3 × percentage positive nuclei) was analysed for association with morphological features, patient age, gender, operability, chemotherapy and survival. P40 H-score in 14 paired FNBs and resections was compared. P40 h-score was 1-3 in 31%, 4-30 in 16% and > 30 in 13% of FNBs. It was significantly associated with intercellular bridges, elongated cell shape, sharp cell borders, angular nuclei with homogenous chromatin (p < 0.001) and dense cytoplasm (p = 0.002). Keratinisation was not seen. Inoperable patients (n = 81) had a shorter median survival for h-score > 30 (n = 9, 1.8 months) than for h-score ≤ 30 (n = 66, 6.7 months) not quite reaching statistical significance (p = 0.08). P40 was significantly associated with squamous morphology in FNBs with PDAC. P40 H-score > 30 showed a trend towards shorter survival in inoperable patients. Squamous differentiation may be a treatment target in PDAC.

Identifiants

pubmed: 34711883
doi: 10.1038/s41598-021-00652-5
pii: 10.1038/s41598-021-00652-5
pmc: PMC8553828
doi:

Substances chimiques

Biomarkers, Tumor 0
TP63 protein, human 0
Transcription Factors 0
Tumor Suppressor Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21290

Subventions

Organisme : Medical Research Council
ID : MR/N005872/1
Pays : United Kingdom

Informations de copyright

© 2021. The Author(s).

Références

Expert Opin Ther Targets. 2018 May;22(5):453-461
pubmed: 29561217
Arch Pathol Lab Med. 2013 May;137(5):668-84
pubmed: 22970842
Mod Pathol. 2005 Sep;18(9):1193-8
pubmed: 15976814
Endoscopy. 2020 Jun;52(6):454-461
pubmed: 32162287
Cancer Res. 2014 Jun 1;74(11):2913-21
pubmed: 24840647
Nat Genet. 2015 Oct;47(10):1168-78
pubmed: 26343385
Cell Rep. 2018 Nov 13;25(7):1741-1755.e7
pubmed: 30428345
Hum Pathol. 2010 Jan;41(1):113-22
pubmed: 19801164
Nat Med. 2011 Apr;17(4):500-3
pubmed: 21460848
Clin Cancer Res. 2018 Jan 15;24(2):351-359
pubmed: 29101303
FASEB J. 2020 Sep;34(9):12214-12228
pubmed: 32686876
J Surg Res. 2012 May 1;174(1):12-9
pubmed: 21816433
EBioMedicine. 2020 Jul;57:102858
pubmed: 32629389
Mod Pathol. 2001 May;14(5):443-51
pubmed: 11353055
Gastroenterology. 2018 Dec;155(6):1689-1691
pubmed: 30419209
Cancer Cell. 2018 Mar 12;33(3):512-526.e8
pubmed: 29533787
Am J Surg Pathol. 2012 Jun;36(6):895-9
pubmed: 22367298
Histopathology. 1983 Sep;7(5):645-61
pubmed: 6313514
Gastroenterology. 2018 Dec;155(6):1999-2013.e3
pubmed: 30165049
Arch Pathol Lab Med. 2012 Apr;136(4):447-53
pubmed: 22458907
Nature. 2016 Mar 3;531(7592):47-52
pubmed: 26909576
World J Gastrointest Oncol. 2015 Sep 15;7(9):132-40
pubmed: 26380056
Clin Cancer Res. 2018 Mar 15;24(6):1344-1354
pubmed: 29288237
J Pathol. 2017 Oct;243(2):155-159
pubmed: 28722109
Cancer Cell. 2017 Aug 14;32(2):185-203.e13
pubmed: 28810144
Surg Today. 2019 Oct;49(10):809-819
pubmed: 30980180
Cancers (Basel). 2019 Jul 10;11(7):
pubmed: 31295960
Gut. 2019 Jun;68(6):1034-1043
pubmed: 30658994
Pathol Res Pract. 2018 Dec;214(12):2069-2074
pubmed: 30477643
World J Gastroenterol. 2016 Nov 28;22(44):9694-9705
pubmed: 27956793
J Cancer. 2016 Jun 25;7(10):1328-39
pubmed: 27390608
Gut. 2020 Feb;69(2):317-328
pubmed: 31201285

Auteurs

Beate Haugk (B)

Department of Cellular Pathology, Royal Victoria Infirmary, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, UK. beate.haugk@nhs.net.

David Horton (D)

HPB Unit, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Kofi Oppong (K)

HPB Unit, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

John Leeds (J)

HPB Unit, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Antony Darne (A)

Department of Cellular Pathology, Royal Victoria Infirmary, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, UK.

Philip Sloan (P)

Department of Cellular Pathology, Royal Victoria Infirmary, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, UK.

Thomas Ness (T)

Department of Cellular Pathology, Royal Victoria Infirmary, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, UK.

Claire Jones (C)

Department of Cellular Pathology, Royal Victoria Infirmary, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, UK.

Paul Bassett (P)

Statsconsultancy Ltd, Amersham, Bucks, UK.

Manu Nayar (M)

HPB Unit, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH